FDA Inspection 1228769 — Reproductive Medicine Associates Of New York, LLP
The FDA completed an inspection of Reproductive Medicine Associates Of New York, LLP on Jan 31, 2024 in New York, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jan 31, 2024
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- New York, NY (United States)